DRKS00025396
Not yet recruiting
Not Applicable
Establishing Pheno- and Genotyping - PrePRECISE
Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel0 sites150 target enrollmentAugust 4, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- F30-F39
- Sponsor
- Institut für Experimentelle und Klinische Pharmakologie, UKSH, Campus Kiel
- Enrollment
- 150
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Informed consent
- •(Planned) use of at least one of the following antidepressants:
- •o citalopram
- •o sertraline
- •o venlafaxine
- •o paroxetine
- •o mirtazapine
- •(Planned) assessment of Hamilton depression scores (HAM\-D17\)
Exclusion Criteria
- •Not of legal age
- •Non\-compliance and other study\-endangering factors as determined by the investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Genotypoing and data collection for the natural cystic fibrosis registryCystic fibrosisHuman Genetics and Inherited Disorders - Cystic fibrosisACTRN12605000734662Australian Cystic Fibrosis Trust
Recruiting
Not Applicable
Congenital heart defectsCTRI/2021/06/034215Department of Biotechnology Ministry of Science and Technology Government of India
Recruiting
Not Applicable
Discovery and validation of genetic markers to establish effective indications of anti-osteoporotic drugsDiseases of the musculo-skeletal system and connective tissueKCT0000426Asan Medical Center6,604
Recruiting
Not Applicable
Investigations on the individual phenotype and genetic profile of sleep apnea syndromeG47.3Sleep apnoeaDRKS00003966Interdisziplinäres Schlafmedizinisches ZentrumCharité Universitätsmedizin Berlin6,000
Recruiting
Not Applicable
Identification of genetic causes and designed therapy by large sized exome data establishment in Charcot-Marie-Tooth diseaseDiseases of the nervous systemKCT0000369Ewha Womans University Medical Center220